➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Johnson and Johnson
Boehringer Ingelheim
Baxter
McKinsey

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Patent: 9,192,361

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,192,361
Title:Fecal microbiome transplant material preparation method and apparatus
Abstract: This invention relates to a fecal microbiome transplant material preparation method and apparatus for the preparation of fecal material for a fecal transplant. A healthy patient\'s stool is collected and deposited in a first container which has its open end attached to a second container to form a fecal processing device. Blender blades are positioned in the second container and a filter is mounted therein. Liquid is injected into the second container through a syringe port having a valve therein to block the escape of liquid from the connected containers. Intake and exhaust ports allow air to enter and escape from the connected containers while blocking the escape of liquid. The liquid and fecal matter in the connected containers is blended and the blended liquid is strained through the filter in the second container and removed through the syringe port for use in a fecal transplant.
Inventor(s): Stevens; Christopher J (Houston, TX)
Assignee:
Application Number:13/776,844
Patent Claims:see list of patent claims

Details for Patent 9,192,361

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial 2039-09-22 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial 2039-09-22 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Johnson and Johnson
Dow
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.